Abstract
The result of a trial may not be accepted for several reasons: the result may be at variance with preconceived ideas; an unusual group of patients may have been recruited; the treatment groups may not be identical in important respects; too few patients may have been recruited and the power of the trial may be too low; the results of the trial may not have been interpreted correctly; the trial result may not be consistent across different strata of patients; the trial may provide a result that conflicts with the results of other trials; the treatment may be difficult to administer or have too many adverse effects; and finally, the trial may originate from a group with a vested interest in demonstrating the observed result (for example, a pharmaceutical company). Before discussing each of these reasons we shall illustrate them by describing three trials whose results have not been completely accepted and also three series of trials on related drugs, the collective results of which are difficult to interpret. After discussing these trials, we shall return to the reasons for rejecting the results of a randomised controlled trial.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Bulpitt, C.J. (1983). Failure to Accept the Results of Randomised Controlled Trials. In: Randomised Controlled Clinical Trials. Developments in Biostatistics and Epidemiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6358-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6358-4_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6360-7
Online ISBN: 978-1-4757-6358-4
eBook Packages: Springer Book Archive